Related references
Note: Only part of the references are listed.The ageing human B cell repertoire: a failure of selection?
D. K. Dunn-Walters
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases
Chantal Edge et al.
JOURNAL OF INFECTION (2016)
Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination
Mariette B. van Ravenhorst et al.
VACCINE (2016)
Linking the seroresponse to infection to within-host heterogeneity in antibody production
P. F. M. Tennis et al.
EPIDEMICS (2016)
Age-related aspects of human IgM(+) B cell heterogeneity
Victoria Martin et al.
B-1 CELL DEVELOPMENT AND FUNCTION (2015)
Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex
Susanne P. Stoof et al.
CLINICAL INFECTIOUS DISEASES (2015)
The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly
Cornelis H. van Werkhoven et al.
CLINICAL INFECTIOUS DISEASES (2015)
Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015
H. Campbell et al.
EUROSURVEILLANCE (2015)
Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans
Axel Ronald Schulz et al.
JOURNAL OF IMMUNOLOGY (2015)
Sex-based differences in immune function and responses to vaccination
Sabra L. Klein et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2015)
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine
K. A. Bryant et al.
VACCINE (2015)
Randomized Clinical Trial To Evaluate the Immunogenicity of Quadrivalent Meningococcal Conjugate and Polysaccharide Vaccines in Adults in the United Kingdom
Maheshi N. Ramasamy et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination
Merijn W. Bijlsma et al.
CLINICAL INFECTIOUS DISEASES (2014)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial
Ghassan Dbaibo et al.
DRUGS & AGING (2013)
The Gracefully Aging Immune System
Diana Boraschi et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
Lisa A. Jackson et al.
VACCINE (2013)
How to define biomarkers of human T cell aging and immunocompetence?
Dietmar Herndler-Brandstetter et al.
FRONTIERS IN IMMUNOLOGY (2013)
Immune senescence and vaccines to prevent herpes zoster in older persons
Myron J. Levin
CURRENT OPINION IN IMMUNOLOGY (2012)
Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?
Pierre Olivier Lang et al.
EXPERT REVIEW OF VACCINES (2012)
B Cell Memory to a Serogroup C Meningococcal Conjugate Vaccine in Childhood and Response to Booster: Little Association with Serum IgG Antibody
Kirsten P. Perrett et al.
JOURNAL OF IMMUNOLOGY (2012)
Age-related changes in human peripheral blood IGH repertoire following vaccination
Yu-Chang Bryan Wu et al.
FRONTIERS IN IMMUNOLOGY (2012)
Age effects on B cells and humoral immunity in humans
Daniela Frasca et al.
AGEING RESEARCH REVIEWS (2011)
Older Adults Have a Low Capacity To Opsonize Pneumococci Due to Low IgM Antibody Response to Pneumococcal Vaccinations
Saeyoung Park et al.
INFECTION AND IMMUNITY (2011)
Gain and Loss of T Cell Subsets in Old Age-Age-Related Reshaping of the T Cell Repertoire
Christoph R. Arnold et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Immunosenescence: Implications for vaccination programmes in adults
Pierre Olivier Lang et al.
MATURITAS (2011)
Promoting Life Course Vaccination
Jean-Pierre Michel et al.
REJUVENATION RESEARCH (2011)
Vaccines for the twenty-first century society
Rino Rappuoli et al.
NATURE REVIEWS IMMUNOLOGY (2011)
microRNA and aging: A novel modulator in regulating the aging network
Li-Hsin Chen et al.
AGEING RESEARCH REVIEWS (2010)
The effect of age on the response to the pneumococcal polysaccharide vaccine
Hyunju Lee et al.
BMC INFECTIOUS DISEASES (2010)
Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998-2007: Implications for Prevention of Meningococcal Disease
Amanda C. Cohn et al.
CLINICAL INFECTIOUS DISEASES (2010)
Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine
Richarda M. de Voer et al.
PLOS ONE (2010)
High tetanus antitoxin antibody concentrations in the Netherlands: A seroepidemiological study
Anneke Steens et al.
VACCINE (2010)
Simultaneous Detection of Haemophilus influenzae Type b Polysaccharide-Specific Antibodies and Neisseria meningitidis Serogroup A, C, Y, and W-135 Polysaccharide-Specific Antibodies in a Fluorescent-Bead-Based Multiplex Immunoassay
Richarda M. de Voer et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults
Richarda M. de Voer et al.
VACCINE (2009)
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2009)
B-cell responses to vaccination at the extremes of age
Claire-Anne Siegrist et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides
Richarda M. de Voer et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus
Pieter G. M. van Gageldonk et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine
H Findlow et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Meningococcal surrogates of protection - serum bactericidal antibody activity
R Borrow et al.
VACCINE (2005)
Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell
YH Shi et al.
JOURNAL OF IMMUNOLOGY (2005)
Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135
G Lal et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2004)
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: Reevaluation of correlates of protection
R Borrow et al.
INFECTION AND IMMUNITY (2001)
Share Paper
